logo.jpg
Addex ADX71149 Demonstrates Synergistic Efficacy with Levetiracetam in Preclinical Models of Epilepsy
September 23, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 23 September 2015...
logo.jpg
Pierre Fabre Pharmaceuticals and Addex Therapeutics Sign Early-Stage Agreement in the Central Nervous System (CNS) Field
September 08, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Addex Grants Option to License mGlu3...
logo.jpg
Alpha Deal Group Initiates Independent Research Coverage on Addex Therapeutics
August 17, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}   Geneva, Switzerland, 17 August 2015 -...
logo.jpg
Addex Dipraglurant Demonstrates Anxiolytic- and Antidepressant-like Activity in Multiple Preclinical Models Relevant for Non-Motor Symptoms in Parkinson's Disease
August 14, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}      Geneva, Switzerland 14 August 2015...
logo.jpg
valuationLAB Issues Research Report on Addex Therapeutics
August 05, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}   Geneva, Switzerland, 5 August 2015...
logo.jpg
Addex Dipraglurant Dosed in First Subject in Receptor Occupancy Study in Collaboration with Johns Hopkins University and with Funding from The Michael J. Fox Foundation
July 22, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 22 July 2015 -...
logo.jpg
Addex Shareholders Appoint Raymond Hill and Tim Dyer to the Board of Directors and approve all Board Proposals at Annual General Meeting
June 12, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 12 June 2015 -...
logo.jpg
Addex Identifies New Potential Use of mGlu7 receptor NAMs to Treat Stress-Induced Visceral Pain
June 03, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}   Geneva, Switzerland 3 June 2015 -...
logo.jpg
Addex and Prof. Pisani Present Dipraglurant data in Rare Inherited Forms of Dystonia
May 29, 2015 01:00 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} 5th Biennial Workshop on Dystonia...
logo.jpg
Addex Annual General Meeting Scheduled for 11 June 2015
May 27, 2015 09:50 ET | Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland 27 May 2015 -...